Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
McKinsey
Colorcon
Mallinckrodt
Boehringer Ingelheim

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Hong Kong Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HONG KONG, and what generic and branded alternatives to HONG KONG drugs are available?

HONG KONG has seven approved drugs.



Summary for Hong Kong
US Patents:0
Tradenames:6
Ingredients:5
NDAs:7

Drugs and US Patents for Hong Kong

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hong Kong BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 205030-002 Apr 20, 2018 AP RX No No   Start Trial   Start Trial
Hong Kong CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077096-003 Jun 14, 2005 AP RX No No   Start Trial   Start Trial
Hong Kong TOPOTECAN HYDROCHLORIDE topotecan hydrochloride INJECTABLE;INJECTION 201166-001 Aug 8, 2012 AP RX No No   Start Trial   Start Trial
Hong Kong CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077096-001 Jun 14, 2005 AP RX No No   Start Trial   Start Trial
Hong Kong CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 077096-004 Jun 3, 2013 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Baxter
Merck
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.